ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-OR15

Induced Senescent Cells Recruit Leukocytes and Permit Their Own Clearance from Healthy Young Kidneys

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Docherty, Marie, The University of Edinburgh Centre for Inflammation Research, Edinburgh, Edinburgh, United Kingdom
  • Reck, Maximilian, The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, Edinburgh, United Kingdom
  • Campbell, Ross Alexander, The University of Edinburgh Centre for Inflammation Research, Edinburgh, Edinburgh, United Kingdom
  • Baird, David Paul, The University of Edinburgh Centre for Inflammation Research, Edinburgh, Edinburgh, United Kingdom
  • Denby, Laura, The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, Edinburgh, United Kingdom
  • Mylonas, Katie J., The University of Edinburgh Centre for Inflammation Research, Edinburgh, Edinburgh, United Kingdom
  • Ferenbach, David A., The University of Edinburgh Centre for Inflammation Research, Edinburgh, Edinburgh, United Kingdom
Background

Increasing evidence links senescent epithelia to fibrosis and functional loss in experimental and human kidney disease. Whether senescent cells themselves are sufficient to initiate and sustain kidney fibrosis is unknown. We hypothesised that induction of epithelial senescence alone, in absence of other renal injuries, is sufficient to initiate and sustain fibrosis.

Methods

We generated a Pax8creERT2;mdm2 fl/fl mouse (‘TG’) via a cross of two established stains and treated these and wild type (WT) mice with tamoxifen by oral gavage to induce epithelial restricted senescence via mdm2 deletion. Markers of fibrosis (Collagen I) and growth arrest (p21cip1) were quantified by immunofluorescence (IF), and total collagen by picrosirius red. Full transcriptomic analysis was undertaken using scRNA-seq (10X).

Results

Tamoxifen resulted in p21cip1 induction in renal epithelia in TG but not in wild WT mice by IF (10.45 ± 2.9 vs 3.15 ± 0.7, p<0.05). On scRNA-seq, TG (but not WT) kidneys contained transcriptionally distinct, cdkn1a+ epithelia, recruited leukocytes and increased activated myofibroblasts. IF confirmed increased renal fibrosis at D7 in TG vs WT (Collagen1 1.1 ± 0.3 vs 3.1 ± 0.5, p<0.005). By D42, scRNAseq analysis demonstrated clearance of cdkn1a+ senescent epithelia, normalisation of leukocyte counts and resolution of myofibroblast activation in TG kidneys, with confirmation by IF; showing no difference in p21cip1 levels between WT and TG mice (2.4 ± 1.4 vs 4.1 ± 1.1, p=0.7) and no progressive fibrosis.

Conclusion

Our results demonstrate that epithelial senescence is profibrotic in absence of injury to other cell lineages. Of importance, mechanisms in the healthy adult kidney allow detection and physiologic clearance of senescence and prevent ongoing fibrosis. Understanding how these pathways are lost with age and chronic injury may lead to new routes to promote clearance of profibrotic senescent epithelia.